Johnson & Johnson Agrees $5.5 Billion Talc Settlement Covering 69,000 U.S. Cancer Cases
Updated
Updated · Al Jazeera English · Jul 28
Johnson & Johnson Agrees $5.5 Billion Talc Settlement Covering 69,000 U.S. Cancer Cases
3 articles · Updated · Al Jazeera English · Jul 28
Summary
$5.5 billion would resolve about 69,000 U.S. federal and state lawsuits alleging J&J's talc-based baby powder caused ovarian cancer, covering 99.75% of outstanding talc cases.
95% claimant approval is still required to finalize the deal, which J&J said would help end a decade-long legal fight even as it continues to deny talc causes cancer.
Talc-based baby powder was pulled from the U.S. in 2020 and worldwide in 2023 as cancer concerns mounted; the WHO classified talc as probably carcinogenic in 2024.
The settlement does not cover the UK, where more than 7,000 potential claimants are pursuing a separate High Court case alleging J&J knew its talc could cause cancer.